Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Total Current Liabilities (2019 - 2023)

Historic Total Current Liabilities for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $78.2 million.

  • ADC Therapeutics' Total Current Liabilities fell 1069.62% to $78.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $78.2 million, marking a year-over-year decrease of 1069.62%. This contributed to the annual value of $81.9 million for FY2022, which is 11072572.53% up from last year.
  • Latest data reveals that ADC Therapeutics reported Total Current Liabilities of $78.2 million as of Q3 2023, which was down 1069.62% from $80.6 million recorded in Q2 2023.
  • ADC Therapeutics' Total Current Liabilities' 5-year high stood at $87.6 million during Q3 2022, with a 5-year trough of $19943.0 in Q4 2019.
  • Over the past 5 years, ADC Therapeutics' median Total Current Liabilities value was $65.0 million (recorded in 2021), while the average stood at $53.0 million.
  • In the last 5 years, ADC Therapeutics' Total Current Liabilities soared by 18200852.81% in 2021 and then crashed by 1069.62% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Total Current Liabilities stood at $19943.0 in 2019, then soared by 63.28% to $32563.0 in 2020, then surged by 108777.75% to $35.5 million in 2021, then skyrocketed by 131.11% to $81.9 million in 2022, then dropped by 4.56% to $78.2 million in 2023.
  • Its last three reported values are $78.2 million in Q3 2023, $80.6 million for Q2 2023, and $81.1 million during Q1 2023.